Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Public ClinicalTrials.gov record NCT07284875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to determine the effects of ribupatide (KAI-9531) subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.
Study identification
- NCT ID
- NCT07284875
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,530 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2025 (Actual)
- Primary completion
- Feb 2028 (Estimated)
- Completion
- Mar 2028 (Estimated)
- Last update posted
- Oct 6, 2026
2025 – 2028
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kailera Clinical Site | Anniston | Alabama | 36207 | — |
| Kailera Clinical Site | Birmingham | Alabama | 35294 | — |
| Kailera Clinical Site | Cullman | Alabama | 35055 | — |
| Kailera Clinical Site | Sun City | Arizona | 85351 | — |
| Kailera Clinical Site | Escondido | California | 92025 | — |
| Kailera Clinical Site | Toluca Lake | California | 91602 | — |
| Kailera Clinical Site | Aurora | Colorado | 80012 | — |
| Kailera Clinical Site | Bridgeport | Connecticut | 06606 | — |
| Kailera Clinical Site | Jupiter | Florida | 33458 | — |
| Kailera Clinical Site | Lilburn | Georgia | 30047 | — |
| Kailera Clinical Site | Springfield | Illinois | 62072 | — |
| Kailera Clinical Site | Columbia | Maryland | 21045 | — |
| Kailera Clinical Site | Las Vegas | Nevada | 89119 | — |
| Kailera Clinical Site | Rochester | New York | 14609 | — |
| Kailera Clinical Site | Morehead City | North Carolina | 28557 | — |
| Kailera Clinical Site | Chickasha | Oklahoma | 73018 | — |
| Kailera Clinical Site | Mauldin | South Carolina | 29662 | — |
| Kailera Clinical Site | Chattanooga | Tennessee | 37405 | — |
| Kailera Clinical Site | Amarillo | Texas | 79124 | — |
| Kailera Clinical Site | Bellaire | Texas | 77401 | — |
| Kailera Clinical Site | DeSoto | Texas | 75115 | — |
| Kailera Clinical Site | Tomball | Texas | 77375 | — |
| Kailera Clinical Site | Salt Lake City | Utah | 84124 | — |
| Kailera Clinical Site | Danville | Virginia | 24541 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07284875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2026 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07284875 live on ClinicalTrials.gov.